Literature DB >> 21855248

Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.

Theodoros Kelesidis1, Romney Humphries, Kevin Ward, Michael A Lewinski, Otto O Yang.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) meningitis is associated with a high mortality rate. Treatment is challenging in patients with allergy to vancomycin. Herein, we describe a case of MRSA bacteremia secondary to medical device infection with MRSA that was complicated by MRSA meningitis. This case provides evidence for a possible role of combination therapy of daptomycin, linezolid, and rifampin in cases of MRSA meningitis and bacteremia.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21855248      PMCID： PMC8053445          DOI： 10.1016/j.diagmicrobio.2011.07.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  15 in total

1.  Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.

Authors:  Molly E Steed; Celine Vidaillac; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin.

Authors:  Dong Heun Lee; Brandon Palermo; Mashiul Chowdhury
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

3.  Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci.

Authors:  Patricia Dandache; Pamela A Moise; Jose Orsini; Marisa Montecalvo; George Sakoulas
Journal:  J Antimicrob Chemother       Date:  2009-09-04       Impact factor: 5.790

4.  Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.

Authors:  Hee-Chang Jang; Sung-Han Kim; Kye Hyoung Kim; Choong Jong Kim; Shinwon Lee; Kyoung-Ho Song; Jae Hyun Jeon; Wan Beom Park; Hong Bin Kim; Sang-Won Park; Nam Joong Kim; Eui-Chong Kim; Myoung-Don Oh; Kang Won Choe
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

5.  In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.

Authors:  José M Entenza; Marlyse Giddey; Jacques Vouillamoz; Philippe Moreillon
Journal:  Int J Antimicrob Agents       Date:  2010-02-24       Impact factor: 5.283

6.  Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.

Authors:  Daniela Baldoni; Manuel Haschke; Zarko Rajacic; Werner Zimmerli; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline.

Authors:  Heather B Jaspan; Adam W Brothers; Angela J P Campbell; John K McGuire; Samuel R Browd; Thomas J Manley; Daniel Pak; Scott J Weissman
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

8.  Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo.

Authors:  Elizabeth C Weiss; Agnieszka Zielinska; Karen E Beenken; Horace J Spencer; Sonja J Daily; Mark S Smeltzer
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

9.  Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone.

Authors:  U Egermann; Z Stanga; A Ramin; F Acosta; A Stucki; P Gerber; M Cottagnoud; P Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

10.  Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.

Authors:  Michael E Olson; Shawn R Slater; Mark E Rupp; Paul D Fey
Journal:  J Antimicrob Chemother       Date:  2010-08-18       Impact factor: 5.790
View more
  11 in total

1.  Should daptomycin-rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?

Authors:  C Stein; O Makarewicz; C Forstner; S Weis; S Hagel; B Löffler; M W Pletz
Journal:  Infection       Date:  2016-01-21       Impact factor: 3.553

2.  Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.

Authors:  Andrew D Berti; Justine E Wergin; Gary G Girdaukas; Scott J Hetzel; George Sakoulas; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

3.  Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.

Authors:  Andrew D Berti; Sarah L Baines; Benjamin P Howden; George Sakoulas; Victor Nizet; Richard A Proctor; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191

Review 4.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.

Authors:  Megan K Luther; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

6.  A case of extensive epidural abscess concomitant with intracranial involvement due to Staphylococcus aureus successfully treated with ceftriaxone in combination with linezolid and rifampin.

Authors:  Kozo Saito; Ryosuke Fukazawa; Shiori Ogura; Takashi Kasai; Toshiki Mizuno
Journal:  eNeurologicalSci       Date:  2018-11-22

7.  A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.

Authors:  Yi-Chien Lee; Pao-Yu Chen; Jann-Tay Wang; Shan-Chwen Chang
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-06       Impact factor: 2.483

8.  Daptomycin and linezolid for severe methicillin-resistant Staphylococcus aureus psoas abscess and bacteremia: A case report and review of the literature.

Authors:  Xiao-Bing Hong; Ze-Lin Yu; Hong-Bo Fu; Ze-Hong Cai; Jie Chen
Journal:  World J Clin Cases       Date:  2022-03-16       Impact factor: 1.337

9.  Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis.

Authors:  S Piva; Antonello Di Paolo; Laura Galeotti; Francesco Ceccherini; Francesco Cordoni; Liana Signorini; Tommaso Togni; Amedeo De Nicolò; Frank A Rasulo; Nazzareno Fagoni; N Latronico; Antonio D'Avolio
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

Review 10.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.